Researchers identify new target for cancer immunotherapy – Medical Xpress
Medical Xpress |
Researchers identify new target for cancer immunotherapy
Medical Xpress Massachusetts General Hospital investigators have found new evidence that the tumor necrosis factor receptor type II (TNFR2) may be a major target for immuno-oncology treatments, which induce a patient’s immune system to fight cancer. TNFR2 is … |
|
Tumor suppressor key in maintaining stem cell status in muscle
Purdue Newsroom WEST LAFAYETTE, Ind. – A gene known to suppress tumor formation in a broad range of tissues plays a key role in keeping stem cells in muscles dormant until needed, a finding that may have implications for both human health and animal production, … |
|
Tumor suppressor key in maintaining stem cell status in muscle
Purdue Newsroom WEST LAFAYETTE, Ind. – A gene known to suppress tumor formation in a broad range of tissues plays a key role in keeping stem cells in muscles dormant until needed, a finding that may have implications for both human health and animal production, … |
|
Massachusetts General researchers identify new target for cancer immunotherapy
EurekAlert (press release) Massachusetts General Hospital investigators have found new evidence that the tumor necrosis factor receptor type II (TNFR2) may be a major target for immuno-oncology treatments, which induce a patient’s immune system to fight cancer. TNFR2 is … |
EurekAlert (press release) |
Immune responses against a virus-related skin cancer suggest ways to improve immunotherapy Fred Hutchinson …
EurekAlert (press release) In April, Nghiem’s group published findings of a phase 2 clinical trial of the immunotherapy drug pembrolizumab, reporting that the “checkpoint inhibitor” helped to revive “exhausted” T cells, providing significant and lasting responses in more than … |